Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Libramont-Chevigny

15 clinical trials in Libramont-Chevigny, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Libramont-Chevigny at a glance
15
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

15 trials in Libramont-Chevigny

Open in trial search
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glatiramer Acetate
  • Sponsor:Genmab A/S
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Genmab A/S
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:AZD5335
  • Sponsor:AstraZeneca AB
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:AstraZeneca AB
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Pharmacosmos A/S
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Exelixis Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Daiichi Sankyo Inc.

Endometrial cancer

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Gad20-209-Fsp-A1
  • Sponsor:Nouscom S.r.l.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ceralasertib
  • Sponsor:AstraZeneca AB

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Libramont-Chevigny

What the registry says about research in the country

01 Libramont-Chevigny
Neoplasms (Cancer)
In Libramont-Chevigny, Belgium, the three actively recruiting studies concentrate on neoplasms, addressing some of the most challenging solid‑tumor indications. Researchers are evaluating novel combination immunotherapies, genetic vaccine strategies, and targeted agents to improve outcomes for patients with advanced cancers. Locally advanced unresectable or metastatic microsatellite instability‑high (MSI‑H) or dMMR colorectal cancer Recurrent or metastatic head and neck squamous cell carcinoma Relapsed small cell lung cancer Combination approaches such as zanzalintinib with pembrolizumab and investigational genetic vaccines These trials aim to demonstrate enhanced anti‑tumor activity, higher response rates, and longer survival compared with standard therapies, offering hope for patients facing limited treatment options.
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.